Pericytes, which are also known as Rouget cells or perivascular cells, are considered to represent a likely distinct pool of vascular cells that are extremely branched and located mostly in the periphery of the vascular system. The family of pericytes is a heterogeneous cell population that includes pericytes and pericyte-like cells. Accumulated data indicate that networks of pericyte-like cells exist in normal non-atherosclerotic intima, and that pericyte-like cells can be involved in the development of atherosclerotic lesions from the very early stages of disease. The pathogenic role of arterial pericytes and pericyte-like cells also might be important in advanced and complicated atherosclerotic lesions via realizing mechanisms of vascular remodelling, ectopic ossification, intraplaque neovascularization, and probably thrombosis.
Introduction
Pericytes, which are also known as Rouget cells or perivascular cells, are considered to represent a likely distinct pool of vascular cells that are extremely branched and located mostly in the periphery of the vascular system. 1 -3 The family of pericytes is a heterogeneous cell population that includes pericytes and pericyte-like cells. 1 -3 The pericytes are in specific touch with the endothelial cells (ECs) through multiple local contacts. 1 The phenomenon may be explained by natural 'feeling' between both cell types that results in co-recognition followed by co-adhesion and co-signalling. 4 The pericytes are embedded within the basement membrane of microvessels and partially wrap ECs. 1 -3 Pericytes are involved in a variety of functions including maintenance of vascular contractility and permeability, control of vascular pressure, angiogenesis, immune defence, production of extracellular matrix (ECM) components, and keeping stability of vessels. 1 -3 In homeostasis, pericytes provide stabilization and nurturing signals to adjacent ECs. 1 -3 During angiogenic branching, pericytes are responsible for orchestrating new vessels to form a functionally efficient network. 5 Pericytes are thought to possess regenerative properties of mesenchymal progenitor cells due to the ability to differentiate other cell types such as macrophages, myofibroblasts, osteoblasts, and adipocytes. 6, 7 This capacity suggests the involvement of pericytes in vascular remodelling and vascular injury healing. 6, 7 However, in pathology, the normal function of pericytes may be biased. 1 -3 For example, in their prefibrotic phase, perivascular cells serve as a source of scar-forming myofibroblasts, which are the major source of ECM components and may lead to fibrosis of multiple organs such as skin, muscles, kidney, liver, and probably lungs. 8 -11 In the affected kidney, pericytes become detached from the endothelium and actively differentiate into myofibroblasts that cause pericyte deficiency at the microvascular interstitial interface, unstable microvasculature, and finally to local ischaemia. 12 Accumulated data indicate that pericytes and pericyte-like cells are present in large arteries. Pericytes were shown to contribute to embryonic organogenesis of the aorta. 13 Besides microvessels, multipotent pericytes can be found in the adventitia of large vessels where they are associated with vasa vasorum microvessels. 14, 15 Furthermore, the presence of stellate pericyte-like cells in the intima of the large arteries has been reported. 16 -21 The existence of pericytes and pericyte-like cells in large arteries might be of fundamental medical relevance, 22 especially with respect to atherosclerosis. 17, 18 In this review, we emphasize findings suggesting the existence of pericyte-like cells in the subendothelial layer of adult human aortic intima and discuss the possible pathophysiological significance of this type of cell in atherogenesis.
Subendothelial cells of the human arterial intima: historical view on the origin
The cell population of the subendothelial arterial intima is heterogeneous. The structural heterogeneity of the subendothelial cell population was first described by Langhans 23 in 1866 and then confirmed by other researchers. 24 -26 Histologically, subendothelial cells are variable cells. 17,24 -26 There are several morphotypes: elongated bipolar cells, stellate cells containing several long thin processes, irregularly shaped cells, ovoid cells, and rounded cells. 17 Among subendothelial resident cells, vascular smooth muscle cells (VSMCs) are the major cell subpopulation that was well defined and histologically recognized starting from early studies. 27 In contrast to a dense regular distribution of VSMCs by cell sheets separated by elastic fibres in the tunica media, subendothelial VSMCs located in the periluminal or proteoglycan-rich layer of arterial tunica intima are randomly distributed forming a network. 27 Compared with VSMCs, other cell subpopulations were chronologically defined later. Anichkov 28 was the first to consider that two distinctive morphological subpopulations of non-VSMCs such as ovoid and rounded cells are likely to have a haematogenous origin, and described these as lymphocytes and macrophages. Indeed, as confirmed later, small round-shaped cells represent blood lymphocytes that infiltrate the intima through the vascular endothelium. 29 -31 Another morphotype of haematogenic cells displaying ovoid shape was confirmed to represent monocytes/macrophages. 26, 32 Macrophages lack the basal membrane and exhibit the presence of micropinocytic vesicles in the proximity to the outer cell membrane. 26 In addition, macrophages spread multiple short finger-like microvilles into the adjacent ECM. 26 The cytoplasm of the latter cells has been shown to contain a few organelles and subcellular structures such as mitochondria, endoplasmic reticulum, and free ribosomes. 26 The kidney-shaped nucleus has a single nucleolus and filled with heterochromatin. 26 In normal human aortic intima, cells of haematogenous origin account for only 5% of the subendothelial cell population. 17 The most striking morphotype of resident cells are stellate cells. Since these cells were first identified by Langhans, 23 3. Implementation of electron microscopy as an instrument for defining subendothelial cells
Implementation of electron microscopy helped obtain a precise image of the fine ultrastructure of subendothelial cells. Those cells, in which cytoplasmic myofibril-like filaments and basal membrane fragments adjacent to the plasmatic membrane have been found, were defined as VSMCs. 42 -46 Since then, the finding of the latter structural elements in any intimal cell was considered as a proof of the VSMC-like nature of such a subendothelial cell. After the use of the term 'intimal modified smooth muscle cells' for the description of myofilament-containing intimal cells by Ross et al. 47 in a classic publication in the American Journal of Pathology in 1984, this term has become commonly used. Eventually, 'intimal modified smooth muscle cells' were found to be different from medial VSMCs by the presence of a well-developed rough endoplasmic reticulum, indicting an increased synthetic activity. 48 -50 The current paradigm is based on an opinion that, in large arteries, there exist two major phenotypes of VSMCs, namely, 'contractile phenotype' in the tunica media and 'secretory phenotype' ('modified smooth muscle cells') in the tunica intima. 49 -51 Electron microscopic observations of the location of some VSMCs in pores of the internal elastic lamina that indicated a principal possibility of migration of cells from the media to the intima, and the observations of rapid transformation of medial 'contractile phenotype' of medial VSMCs into 'secretory phenotype' VSMCs in in vitro conditions, have formed the base and serve as evidence for the current paradigm, postulating that the major cell elements of the arterial intima that contains myofibril-like filaments are 'modified smooth muscle cells'. 49, 51, 52 As such, to date, the VSMC-related progenitor theory of the origin of subendothelial cells is prevalent.
31,50 -52
However, the presence of myofibril-like filaments and basal membrane fragments adjacent to the plasmatic membrane in subendothelial cells cannot exclude a possibility that those cells also have properties of pluripotent mesenchymal progenitor cells with the capability to differentiate to fibroblasts, macrophages, ECs, or VSMCs. 53 Also, as an alternative point of view, it has been suggested that, in the intima of large arteries, there is a special subpopulation of myofibril-containing subendothelial cells which represent pericytes or/and pericyte-like cells that possess pluripotency.
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4. Can some arterial subendothelial cells represent pericytes?
As mentioned above, pericytes normally reside along capillaries, small arteries, and post-capillary venules. 54, 55 The shape of pericytes is elongated with many thin branched and expanded processes. 64 Immunohistochemistry unarguably confirmed that the predominant proportion of arterial intimal cells is constituted by a-smooth muscle actin (a-SMA)-positive cells. 65 However, it is worth noting here that there is also a substantial percentage of the resident subendothelial intimal cells that are negative for a-SMA, a marker that is commonly used as a defining marker of VSMCs. 65 The nature of these cells is still unknown, but histologically they remind of VSMCs. 65 The lack of a-SMA may be a result of phenotypic modulation to which intimal cells are subjected during either physiological adaptation or pathological changes in the vascular wall. 65 The presence of well-developed contractile apparatus is not too crucial for aortic intimal cells since other mechanisms might be involved in the regulation of vascular tone in the aorta and other large arteries. 52, 65 The resident intimal cells of large arteries have been implicated in the performance of other functions such as nutrition, maintaining metabolic homeostasis, or immune response in the vascular wall. 52 Interestingly enough, some a-SMA-positive resident subendothelial intimal cells have been shown to express macrophage-'specific' antigen CD68. 66 These cells have a stellate shape with long dendroid-like processes. In primary cultures of human aortic intimal cells isolated from zones unaffected by atherosclerosis, an addition of atherogenicmodified low-density lipoproteins (LDLs) leads to intracellular lipid accumulation. The proportion of cells positive for both CD68 and a-SMA has been shown to increase in lipid-loaded cell culture. 66 In atherosclerotic lesions, the numbers of CD68 + /a-SMA + cells are also increased compared with the grossly normal (non-atherosclerotic) intima. 66 It becomes clear that the presence of CD68 antigen may not be indicative of a monocytic origin of a cell, but is rather a marker of the cell phagocytic activity. O-syaloganglioside located in the cell surface of microvascular pericytes and is considered to be specific marker for microvascular pericytes. 72 Using a 3G5 monoclonal antibody, pericyte-like cells that are not associated with capillaries have been identified in bovine and human normal aortic intima and in human atherosclerotic plaques complicated with ectopic calcification. 71 Immunohistochemistry clearly demonstrates that, in normal arteries, 3G5-positive cells form a network in the subendothelial layer ( Figure 1A ). Electron microscopic examination of the same intimal areas shows the presence of stellate cells that contain myofibrillike filaments and basal membrane and which, through cell processes, form networks ( Figure 1B ). Contacts between cellular processes are formed by gap junctions ( Figure 1C ). In normal non-atherosclerotic arteries, pericyte-like 3G5-positive cells were found to be located in the subendothelial layer of aortic intima and enveloped by the endothelium of capillaries of vasa vasorum in the adventitia. 21 The subendothelial identification of 3G5-positive cells suggests a relation in the origin between intimal pericyte-like cells and microvascular pericytes, and for the similarity in their functions. 21 In atherosclerotic lesions, contacts between these cells become lost ( Figure 1D ). Consecutive events of alteration of the network of pericyte-like cells that occurs during the development of atherosclerotic lesions are depicted in a scheme shown in Figure 1E . Pericyte-like cells have been identified in bovine and human normal aortic intima and in human atherosclerotic plaques complicated with ectopic calcification. 71 In humans, 3G5-positive cells account for approximately one-third of intimal cells, whereas their population is significantly reduced, by 6-fold, in fibroatheroma. 66 It is well known that the development of atherosclerotic lesions is accompanied by the ingrowth of vasa vasorum into atherosclerotic plaques. 73 In microvessels of plaque neovascularization, ECs are surrounded by pericytes ( Figure 2A -D) that display an appearance typical to that of pericytes in other organs and tissues.
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Another pericyte-specific antigen, 2A7, was also found in the intima large arteries. 66, 74 The antigen 2A7 that is thought to be expressed by pericytes during the active angiogenesis phase in vascular injury healing is the high-molecular-weight melanoma-associated antigen, also known as melanoma chondroitin sulfate proteoglycan. 75 The maximum levels of the antigen 2A7 have been observed in the late fibrotic atherosclerotic plaque, especially in the fibrotic cap of the lesion. 66 Morphologically, in aortic intima, all 2A7-positive cells possess a stellate shape but, in primary culture, stellate 2A7-positive cells become large cells with a polygonal shape due to spreading. 66 The antigen 2A7 is thought to be expressed in activated pericytes including proliferating cells, whereas expression of 3G5 is observed predominantly in quiescent pericytes. 72 Experiments with primary cultures of subendothelial cells derived from normal human aorta and treated with modified LDL showed a significant decrease in the fraction of 3G5-positive cells and an increase in the 2A7-positive cells' fraction, while there were no significant changes in the number of 2A7 + 3G5-positive cells.
74 A 1.5-to 2-fold increase in the intracellular deposition of LDL has been shown to result in a fourfold reduction in the percentage of 3G5-positive cells in cultured subendothelial cells. Proatherogenic lipid load may be primarily involved in functional alterations of pericyte-like cells in atherosclerotic aorta followed with changes in the expression of pericyte-specific antigens. 74 It has been found that there also exists a special subpopulation of pericytelike cells in the periluminal proteoglycan-rich sublayer of the subendothelial aortic intima. 66 They express not only a-SMA, both antigens 2A7 and 3G5, but also CD68 antigen. 66 In atherosclerotic lesions, some stellate cells have been shown to be overloaded with lipids. 76 While the total cell population typically doubles in plaques, the numbers of stellate cells are elevated by six-fold. 17 Therefore, in affected atherosclerosis regions of the aortic wall, the count of pericyte-like cells is increased in and their functionally is altered compared with the grossly normal wall. 66 Comparative analyses of subendothelial intimal cells in the grossly normal and atherosclerotic aorta suggest the likely involvement of pericyte-like cells in atherogenesis. 66 
Three-dimensional cellular networks in aortic intima
On the basis of the examination of intimal en face preparations, Schön-felder 36 has suggested that the stellate cells of the intima are combined into a common network. The existence of a common cellular network in the intima was confirmed by a number of further studies. 19, 66, 77 Using scanning electron microscopy, Rekhter et al. 19 showed that, in the proteoglycan-rich sublayer of areas unaffected by atherosclerosis in the aortic intima, all cells are in contact with each other in a horizontal plane, forming a common network. Cells located at different levels are also connected together, forming a connection between networks located at different levels, and thus forming a three-dimensional cellular network. 19 In early atherogenesis, dissociation of cellular network was found in the proteoglycan-rich sublayer of atherosclerotic lesions, which finally results in the complete isolation of cells from each other in atherosclerotic plaques. 78 To study possible reasons for the decrease in intercellular communication in atherosclerotic lesions, using primary culture cells of the aorta, Andreeva et al. 78 found that the degree of contact communication in cultures derived from normal (unaffected by atherosclerosis) intima is 1.5 times higher than in cultures obtained from atherosclerotic lesions. 78 A characteristic feature of primary cell cultures derived from atherosclerotic lesions is the presence of lipid-rich cells often having a foam structure. 76 In cultures from atherosclerotic lesions, the degree of contact communication of cells without lipid inclusions was found to be about the same as in cells cultured from unaffected atherosclerosis intima. 78 The degree of contact communication of foam cells was found to be two times lower than that of cells without lipid inclusions. 78 It can be assumed that the accumulation of intracellular lipids is a cause of reducing the intercellular communication in the intimal cellular network. Accumulating evidence indicates that, in both normal and atherosclerotic intima, the population of intimal stellate cells consists of different cell types. In particular, there is a network formed by specialized vascular dendritic cells in the subendothelial layer of the normal arterial intima of adults. 79, 80 Millonig et al. 81 have described a 'network of HLA-DR intima. It is important to stress here that an intense expression of antigen-presenting molecules such as HLA-DR is not characteristic for antigen-presenting dendritic cells only, but is also described for stellate cells of non-dendritic cell origin. 82, 83 Notably, dendritic cells constitute just a small portion of the cellular population of a common HLA-DR + network. 82 One cannot exclude that the dominant cell type, forming the HLA-DR + network, may be represented by stellate HLA-DR + pericyte-like cells. 82 The fact that intimal pericyte-like cells form a continuous network in the normal arterial intima and that this network is altered in the very earlier stages of atherogenesis suggests that intimal pericyte-like cells play an important role in the development of atherosclerotic lesions. However, the investigation of intimal pericyte-like cells in large arteries is in its infancy. The studies directed to the analysis of functional impact of pericyte-like cells to the development of atherosclerosis are notably limited; there are just several works that investigated the behaviour of 
Roles of pericytes in different anatomical locations in normal and pathophysiological states
The current information about the functional aspects of pericytes residing in the large arteries is limited, whereas the existing knowledge about pericyte biology in other anatomical locations indicates that pericytes are an important cell type in the maintenance of tissue homeostasis. This knowledge also indicates that pericytes play important roles in tissue reparation and in the development of disease states.
Pericytes in microvascular wound healing
The major role of microvascular pericytes is maintaining of stability and integrity of microvessels. 1 -4 Microvascular pericytes also contribute to neovascularization and microvascular repair in vascular wounds. In normal conditions, pericytes closely interact with ECs. 1 -4 In co-cultures of pericytes and ECs, latent transforming growth factor-b (TGF-b) dissociates from a complex with carrier proteins and becomes active thereby promoting endothelial quiescence and capillary stability. 84 However, microvascular damage and hypoxic stress can induce angiogenic switch in pericyte phenotype towards inducing contractility, and this process is regulated by Rho GTPases. 85 Furthermore, Rho GTPasedependent signalling is involved in the regulation of proliferative status of ECs, pericyte-endothelial interactions, and control the extent of neovascularization. 85, 86 For example, RhoA1 GTPase supports capillary stability and barrier properties in basal conditions, but becomes involved in barrier dysfunction after activation of ECs by thrombin or vascular endothelial growth factor (VEGF).
86
In Matrigel-derived co-cultures, EC precursors able to spontaneously form capillary-like networks, and pericytes were shown to be closely associated with these networks. 87 This observation suggests that pericytes may guide migration of precursors and tube formation in wounded area, and this property of pericytes is applicable to the vascular injury healing. 87 When microvessels are damaged, pericytes become involved in active crosstalk with infiltrating inflammatory cells (monocytes, macrophages, neutrophils, and T cells) and connective tissue cells (myofibroblasts and fibroblasts). 6 Pericytes and macrophages have overlapping functions and may drive wound neovascularization. 6 Brain pericytes possess phagocytic properties, 88 which could be induced by wound stimuli. 89 Indeed, brain pericytes could remove cell debris such as non-functional 'dark' neurons and empty it to capillaries. 90 However, it is unclear whether microvascular pericytes from other tissues are capable to phagocytize. Macrophage and pericyte interactions result in increased macrophage mobility and migration. 6 Bone marrow-derived pericytes and macrophages were found to form branched vascular tubular structures in Matrigel upon stimulation with fibroblast growth factor (FGF)-2. 91 It has been reported that both pericytes and macrophages can efficiently cooperate while contributing to neovascularization and then stabilizing new vessels. 6 Pericytes could recruit lymphocytes to inflamed tissue. 92, 93 In damaged vessels, pericytes release chemokine CXCL12 able to bind to the CXCR4 receptor on the surface of T cells and therefore to attract T lymphocytes to wounded areas. 92 Pericyte could influence lymphocyte infiltration into damaged tissue via increased expression of adhesion molecules such as intercellular adhesion molecule-1 and vascular cell adhesion molecule-1.
93
Connective tissue cells such as fibroblasts and myofibroblasts contribute to wound healing through secretion of multiple growth factors, matrix remodelling, and contractile forces. 6, 94 In response to secretion of platelet-derived growth factor (PDGF) by platelets, fibroblasts release a variety of growth factors including PDGF, FGF-2, VEGF, TGF-b, and epidermal growth factor (EGF) that stimulate vascularization, epithelialization, and wound contraction. 94 Activated fibroblasts can also differentiate to myofibroblasts. 95 Contractility of myofibroblasts supports spreading of capillaries into wounded areas. 96 A variety of growth factors secreted by fibroblasts induces phenotypic changes in pericytes including contractility, ability to produce ECM, and finally pericytemyofibroblast transition. 96 In normal wound healing, transformation of pericytes to myofibroblasts is well controlled in order to prevent tissue fibrosis. 96 However, in pathological conditions, advanced expression of growth factors could impair pericyte function towards uncontrolled pericyte-myofibroblast transition and initiate tissue fibrosis. 96 
Renal pericytes in normal and injured kidney
Accumulated evidence indicates that tissue fibrosis induced through overactivated capacity of pericytes to transform into scar myofibroblasts could affect many tissues. 96 In this respect, the most information is available on kidney fibrosis, in induction and progression of which renal pericytes play a central role. 9, 97, 98 Pericytes were shown to be abundant in renal vessels. 9 In the kidney, the pericytes are located in the subendothelial area, in close contact with the ECs. 9 The kidney pericytes express a variety of markers. 8, 9, 97, 98 During nephrogenesis, the metanephric mesenchymal progenitor cells start to express forkhead box D1 (Foxd1), a transcription factor that plays a key role in the kidney development. 97 In the embryonic kidney, Foxd1-positive cells fate to become pericytes, perivascular fibroblasts, VSMCs, and mesangial cells. 98 Perivascular fibroblasts and pericytes are both expressed type 1 collagen (ColA1). 8, 9 However, compared with pericytes, perivascular fibroblasts have no direct contact with the ECs. During kidney organogenesis, embryonic pericytes express markers such as a-SMA and neuron-glial antigen 2 (NG2) that disappear later in quiescent adult renal pericytes.
8,9
Asada et al. 99 found a population of mesenchymal cells that migrated from the neural crest to the nephrogenic interstitial mesenchyme zone in early kidney developmental stages. This zone was shown to be identical to the region where FoxD1+ progenitors reside before moving to the renal stroma. In the adult kidney, mesenchymal cell progenitors differentiated into mesenchymal cells positive for PDGF receptor (PDGFR)-b and CD73. 99 The mesenchymal cells were capable to attach to capillaries and produce erythropoietin (EPO). 99 Although
Asada et al. 99 described these cells as resident fibroblasts, according to an opinion of Humphreys et al. 98 these cells are likely to represent true pericytes therefore arising from the neural crest progenitors. Recently, Rojas et al. 100 have reported that these ColA1-producing cells are positive for PDGFR-b and CD73, but negative for a-SMA and CD45. In kidney injury, pericytes contribute to renal fibrosis through transition into scar-producing myofibroblasts. 9, 98, 101 Histologically, renal fibrosis represents advanced ECM deposition associated with preferential production of type I collagen and infiltration with proinflammatory
Pericyte-like cells in arteries dendritic cells and monocytes/macrophages, reducing capillary density, and tubular deterioration. 101 In kidney fibrogenesis, scar-producing myofibroblasts mainly (over 50%) arise from the renal resident pericytes, 98 followed by myofibroblasts derived from bone marrow (35%), endothelial-to-mesenchymal transition (10%), and epithelial-to-mesenchymal transition (5%). 102 Lin et al. 9 observed only few bone marrowderived cells expressing green fluorescent protein under control of the Col1a1 promoter (Col1a1-GFP) in the perivascular area of the ischaemia-reperfusion injured kidney in sublethally irradiated C57BL/ 6 mice after transplantation of bone marrow from Col1a1-GFP transgenic mice. The finding suggests that contribution of circulating fibroblasts to the origin of renal myofibroblasts seems to be low (,0.1% of the total myofibroblast population). 9 In healthy kidney, pericytes are primarily involved in the maintenance of normal endothelial function and supporting microvascular stability. 96 To maintain microvascular homeostasis, renal pericytes produce potent angiogenic factors (VEGF-A and angiopoietin-1) and tissue inhibitor of matrix metalloproteinases (MMPs) TIMP-3 that suppresses vascular remodelling and kidney fibrosis. 103 The bidirectional ephrinB2 ligand/ ephrin B4 receptor signalling is implicated in the regulation of developmental angiogenesis. Ephrin B4, a receptor for ephrin-B2, mediates venous angiogenesis, whereas the intracellular PDZ domain of the ephrinB2 ligand is involved in so-called reverse signalling essential for supporting arterial angiogenesis. 104 In mice lacking the PDZ domain of ephrinB2 ligand, renal pericytes and ECs have impaired function. 104 The pericytes are less potent in stabilizing microvessels, while ECs are less responsive to proangiogenic stimuli of VEGF-A. 105 Mice lacking the PDZ domain of ephrinB2 ligand are prone to renal fibrosis and decreased peritubular capillary density in kidney injury. Indeed, the reverse ephrinB2 ligand-mediated signalling in renal pericytes and ECs is important for maintaining kidney microvascular stability and the prevention of pericyte-to-myofibroblast transition and kidney fibrosis. 105 In the affected kidney, increased production of VEGF-A by epithelial cells in renal tubules was shown to activate fibroblasts and their transition to myofibroblasts. 106 Since VEGFR is expressed in ECs, VEGF-A-dependent activation of ECs is likely to contribute to renal fibrosis through induction of PDGF, TGF-b, and inflammatory response. 107 In kidney injury, tubular epithelial cells, ECs, and macrophages produce increased levels of PDGF that in turn stimulates PDGFR expressed exclusively in renal pericytes and myofibroblasts. Overactivation of the PDGF/PDGFR signalling was associated with enhanced renal pericyte-myofibroblast transition. 107 Normally, peritubular capillaries (PTCs) are non-angiogenic. 108 Angiogenesis induced by kidney injury such as chronic tubulointerstitial injury due to the loss of VEGF production by sclerotic glomeruli was shown to cause an adaptive secretion of VEGF-A by kidney tubules. 108 However, due to interstitial fibrosis, a progressive loss of PTCs associated with tubular atrophy and tubular loss is observed along with the development of chronic tubulointerstitial disease. 108 Similarly, an initial activation of ECs in PTCs followed with induction and subsequent reduction in tubular VEGF production and increased apoptosis of PTC ECs was detected in experimental obstructive nephropathy. 109 The proinflammatory cytokine TGF-b is a key mediator of renal inflammation and fibrosis. Interaction of TGF-b with TGF-b type II receptor (TGFbRII) results in activation of TNFbRI and a SMAD family of signal-transducing proteins. 110 In normal kidney, TGF-b is expressed by glomeruli (ECs and mesanglial cells) and distal tubules, whereas in diseased kidney, TGF-b is significantly up-regulated in proximal tubular ECs and interstitial macrophages. 111 TGF-b was shown to contribute to G2/M cell cycle arrest in injured tubular ECs and induction of expression of profibrotic cytokines in ECs that, in turn, stimulate pericyte-myofibroblast transition. 112, 113 Along with stimulatory effects of fibrinogenic growth factors, overactivation of canonic Wnt/b-catenin signalling also contributes to organ and tissue fibrosis, including liver 112 and skeletal muscle. 113 Recently, up-regulated Wnt signalling was shown to be involved in renal fibrosis. 114 Kidney pericytes and myofibroblasts were shown to have on their surface essential Wnt receptors, such as Frizzled cell surface receptors and the low-density lipoprotein receptor protein 5 and 6 (LRP5 and LRP6) co-receptors. 114 In fibrosis, medullary and interstitial myofibroblasts express Wnt4 ligand that binds to LRP5/6 and drives myofibroblast differentiation to pericyte-like cells thereby suggesting on a likely involvement of Wnt4 in pericyte-to-myofibroblast transition. 114 In pericyte plasma membrane, LRP6 closely interacts with PDGFRb and TGF-bR1 and may block stimulatory effects from PDGF and TGF-b1. Dickkopf-related protein 1 (Dkk1), an inhibitor of Wnt/ b-catenin signalling, binds preferentially to LRP6 and in turn suppresses PDGF-mediated pericyte proliferation and migration and cytoskeletal reorganization induced by connective tissue growth factor (CTGF) or TGF-b. 115 Thus, Dkk1 could effectively inhibit renal fibrosis by preventing activation of Wnt signalling in pericytes. 115 Finally, in injured kidney, pericytes can contribute to renal fibrosis by induction of a disintegrin and metalloproteinase with thrombospondin motif 1 (ADAMTS1) and down-regulation of its inhibitor, TIMP-3. 103 By degrading the microvascular basement membrane, ADAMTS1 destabilizes integrity of capillary tubular networks and in turn contributes to profibrotic pericyte activation and migration. 103 It is important to note here that physiologically, the heart and the kidney are interconnected and thus, one cannot exclude that alterations in functioning of renal pericytes might be indirectly affect the development of atherosclerosis. Chronic kidney failure is widely considered as an independent risk factor for cardiovascular disease. 116, 117 Cardiovascular disease is the leading cause of death in patients with end-stage renal disease. 116 Cardiorenal syndrome (CRS) is a disease where acute or chronic dysfunction in one organ may induce dysfunction in the other one organ. 118 To date, five CRS types are distinguished including two types where initial kidney dysfunction leads to acute heart failure (type III) or chronic cardiovascular dysfunction (type IV). 119 In patients with chronic kidney disease (CKD), multiple vascular abnormalities are observed including decreased arterial elasticity/compliance, arterial wall thickening, increased intima-media thickness, and vascular calcification, e.g. all major hallmarks of vascular atherosclerotic disease. 120 Since renal pericytes contribute to kidney fibrosis associated with interstitial scarring, tubule atrophy, and progressive chronic renal insufficiency, adverse cardiovascular consequences of impaired kidney function may be considered as delayed and indirect effects of impaired function of kidney pericytes on arterial atherosclerosis. 121 When the proximal tubule is injured, Na
, uric acid, and inorganic phosphate reabsorption are altered resulting in low bicarbonate (metabolic acidosis), uraemia, impaired phosphate, and salt homeostasis. Metabolic acidosis seems to have no major effects on atherogenesis, but it may contribute to atherogenicity via facilitating oxidation of LDL 122 and increasing the interaction of arterial glucosaminoglycan with plasma LDL. 123 CKD-related hyperphosphataemia is primarily and independently associated with an increased risk of arterial calcification. 124 In uraemic CKD patients and atherosclerosis animal models with experimentally induced anaemia, atherosclerotic plaque progression and vascular calcification are significantly accelerated 125 due to marked proinflammatory, proatherogenic, and cytotoxic effects of A.N. Orekhov et al.
small-molecule uraemic toxins such as indoxyl sulfate and p-cresyl sulfate. 126 Owing to an increased pericyte-myofibroblast transition rate in kidney fibrosis, pericyte-dependent production of EPO is reduced causing anaemia, an adverse event frequently associated with congestive heart failure and other cardiovascular diseases. 127 
Retinal pericytes in diabetic retinopathy
Diabetic retinopathy (DR) is a microvascular diabetic complication that results from the pathological changes in retinal microvessels. 128 This ocular pathology, which can eventually lead to blindness, is a common event in people with long-term diabetes. 128 The retina has the highest pericyte density of all vascular beds. 129 Retinal pericytes and ECs are key players in DR pathogenesis especially in proliferative DR. 129 Diabetic hyperglycaemia, oxidative stress, and advanced glycation endproducts can induce platelet hyperreactivity resulted in enhanced adhesion, activation, and aggregation of blood platelets. 130 Impaired platelet function may in turn produce microthrombi in retinal microvessels. 130 Microthrombi release a variety of vasoactive factors that could destabilize integrity of retinal capillaries, induce microaneurysms, and cause capillary leakage, haemorrhage, and entrance of hyperglycaemic plasma to perivascular areas. 131 Microvascular occlusion and thrombosis lead to hypoxic stress, which in turn induces proangiogenic activation of retinal ECs and stimulates production of VEGF, PDGF-B, and TGF-b. 131 Inflammatory and angiogenic (PDGF, VEGF, and TGF-b) stimuli could induce a potent angiogenic switch in the phenotype of retinal pericytes. Pericytes support burst in proliferation and mobility of activated ECs towards neovascularization. However, hyperactivated pericytes become detached from ECs and are not able to provide essential stability for newly formed capillary networks. Due to advanced dysfunction of retinal ECs, the permeability of existing and novel microvessels is increased causing blood leakage and formation of new haemorrhages. 132 A progressive loss of retinal pericytes is a hallmark of proliferative DR. 133 Proliferative retinopathy invariably develops when pericyte density falls ,50% of normal. 134 Apoptosis is suggested to be the major cause of pericyte death. 135 Multiple mechanisms may be involved in depletion of retinal pericytes. Hyperglycaemia was shown to contribute to pericyte apoptosis through activation of protein kinase C-d and p38a mitogen-activated protein kinase that in turn stimulate Src homology-2 domain-containing phosphatase-1. 136 Modified (e.g.
highly oxidized and glycated) LDLs were found to cause apoptosis in pericytes via induction of oxidative stress and endoplasmic reticulum stress. 137 In DR, retinal pericytes express immunosuppressive molecules such as programmed death-ligand 1 and interleukin (IL-10) that suppress proinflammatory T cells. 138 Indeed, retinal pericytes are prone to inflammation, and their elimination of lymphocytes is essential to the stability of the microcirculation. At early stages of DR progression, proangiogenic and activation behaviour of retinal ECs and pericytes show many similarities with mechanisms of wound-induced microvascular repair. 139 In fact, DR-related cellular and molecular changes could be considered as a misregulated healing response. 140 
Microvascular pericytes and tumour angiogenesis
Tumour pericytes is an interesting example of deep phenotypic changes of perivascular pericytes induced by the tumorigenic pathological microenvironment. Tumours develop abundant microvascular and capillary networks since tumour cells permanently require supply with nutrients and oxygen. 141 However, tumour capillaries grow in response to pathological and stressful stimuli such as malignancy, wound healing, metabolic stress, hypoxia, and inflammation. 141 As a consequence, structurally and morphologically, tumour capillaries are markedly differed from normal capillaries. 141 Rapidly growing tumours tend to develop the 'immature' vasculature associated with continuous capillary formation and remodelling. The abnormalities in tumour vasculature result from aberrant function of pericytes and ECs. 142, 143 Tumour vessels lack hierarchical branching and are chaotically distributed within the tumour mass. 142 Due to irregular and impaired cell-to-cell attachment and increased permeability, tumour microvessels are dilated and leaky. 142 The basement membrane is frequently interrupted and has multiple structural defects facilitating migration of malignant ECs and tumour cells. 142, 143 Tumour pericytes abnormally loose association with microvessels tending to lift off endothelium and extend cytoplasmic processes deep into the tumour tissue. Myofibroblasts could be attached to pericytes, but are freely distributed in the stroma, with limited association with microvessels. The pericyte coverage of tumour vessels varies depending on the tumour type. In glioblastoma multiforme, pericytes are usually rare in the tumour vasculature 144 while they can cover up to 97% vessels in insulinomas. 145 Tumour pericytes can express a variable set of markers. In pancreatic neuroendocrine tumours, pericytes are positive for a-SMA, NG2, desmin, and PDGFRb. 146 Endosialin (CD248) that is not expressed in the normal human adult brain was found to be significantly up-regulated in tumour pericytes in high-grade glioma tumours. 147 Interestingly, a recent study demonstrated that glioblastoma stem cells could contribute to tumour angiogenesis by differentiating into vascular pericytes. 148 Tumour stem cells frequently reside in perivascular niches and may undergo mesenchymal differentiation. Differentiation of stem cells into neoplastic pericytes is controlled by ECs via the CXCL12/ CXCR4 axis and preferentially supported by TGF-b. 148 In tumours, pericytes could be recruited through several mechanisms. PDGF-BB (a homodimer formed by two B subunits of PDGF) is frequently up-regulated in tumours. Since tumour pericytes express PDGFRb on their surface, PDGF-BB produced by ECs and other cells is essential for pericyte recruitment that in turn leads to increased association between ECs and pericytes, neovascularization, and induction of VEGF production in tumour neovessels. 149, 150 However, in murine fibrosarcomas, hyperexpression of PDGF-BB alone in tumour cells resulted in detachment of VSMCs from tumour vessels and poor recruitment of pericytes. Simultaneous overexpression of PDGF-BB and FGF-2 caused formation of highly dense immature vascular networks with limited incorporation of pericytes and VSMCs. 151 This observation suggests that PDGF-BB and FGF-2 could interplay reciprocally leading to disorganized neovascularization and metastasis. Inducing the expression of PDGFR-a and b, FGF2 sensitizes tumour ECs to respond to PDGF-BB, which feeds back to and induces expression of FGF receptor-1 to enhance VSMC responses to FGF2 stimulation. 151 TGF-b supports tumour neoangiogenesis through activation of pericytes and increasing ECM deposition. 152 Angiopoietin-1 and 2 exhibit diverse effects on tumour vasculogenesis. In angiopoietin-1-expressing b-cell tumours, newly formed vessels had limited permeability and were stable enough due to the proper functional recruitment of pericytes and VSMCs, whereas the expression of angiopoietin-2 resulted in developing dilated, non-functional, highly leaking, and haemorrhagic vessels due to the diminished pericyte recruitment. 153 Angiopoietin-2 plays a complex role in the regulation of vascular remodelling that leads to either vessel sprouting (if VEGF co-stimulation is present) or regression (if VEGF is lacking). 154 Sphingosine-1-phosphate was shown to have a potent activating effect on tumour angiogenesis through Rac small GTPase-mediated stimulatory effects on ECs, which in turn activate pericytes. 155 MMPs whose expression is up-regulated in tumours are also involved in the recruitment of pericytes through mechanisms of ECM degradation, releasing ECM-bound growth factors, and supporting proangiogenic signalling. 156 The precise role of tumour pericytes is still unclear. In aggressive, rapidly growing tumours, pericytes are constitutively activated towards supporting neovascularization and immature phenotypes of neovessels. 141, 142 In stable and less aggressive tumours, pericytes can maintain a residual function focused on stabilizing vascular integrity, regulating blood flow, and suppressing proliferation of ECs. 141, 142 The utility of pericytes for anti-angiogenic therapy of tumours is also still disputable. 22, 157 Targeting VEGFR2 was shown to do not cause significant tumour vessel regression due to protective role of pericytes that stabilize tumour vasculature and support EC survival through the angiopoietin-1-dependent pathway. 158 Accordingly, blockage of VEGFR1 in cancer-induced retinopathy did not reduce a population of pericytes but, in contrast, significantly restored pericyte density in mature retinal vessels. 159 It has been suggested that targeting of both tumour pericytes and ECs can improve the efficiency of anti-angiogenic treatment. 160 Cao et al. 159 showed that using of both VEGF and placental growth factor (PlGF) in the treatment of cancer-induced retinopathy resulted in ablation of retinal pericytes. VEGF and PlGF can form nonfunctional heterodimers that in turn bind to the pericyte VEGFR1 and suppress pericytes by blocking the stimulatory effect of VEGF signalling. 161 PDGFRb is essential for stability of tumour neovessels since the receptor is involved in recruitment of pericytes. 162 Therefore, targeting PDGFRb was suggested to be beneficial for destabilization of tumour vasculature and suppression of angiogenesis. 162 Recently, Ruan et al. 163 reported efficiency of Imatinib, a tyrosine kinase inhibitor of platelet-derived PDGFRb, in impairing lymphoma growth via direct targeting PDGFRb+ pericytes and inhibition of PDGF-BB signalling in both human xenograft and murine allograft models. Simultaneous targeting VEGFR on ECs and PDGFRs on adjacent pericytes resulted in specific depletion of a subset of a-SMA-and PDGFRb-positive and desmin-negative pericytes partly detached from the tumour vessels, but did not affect desmin-positive pericytes closely attached to the endothelium. 164 A partial efficiency of anti-PDGF drugs against tumour angiogenesis can be explained by a dual effect of the drugs on tumour vasculature. In tumours with high production of PDGF-BB, anti-PDGF drugs are efficiently blocked tumour growth and metastasis. In tumours lacking PDGF-BB production or expressing low PDGF-BB levels, anti-PDGF drugs may enhance tumour growth and invasiveness by ablating pericytes from tumour vessels. 165 The persistent exposure of pericytes to PDGF-BB inhibits PDGFR-b-mediated signalling in pericytes that leads to decreased adhesion and increases detachment of perivascular cells from the vessels. A combination of VEGF-A and PDGF-B in angiogenic therapy leads to a prolonged angiogenic response, which is mediated through paracrine (e.g. cell-to-cell contacts) mechanisms rather than by Figure 3 Differentiation plasticity of pericytes (scheme 71 Differentiation plasticity of pericytes is reflected in a scheme presented in Figure 3 .
Molecular mechanisms responsible for the induction of proatherogenic differentiation of pericytes to other cell types are widely unknown. T-cadherin, an unusual member of the cadherin family of adhesion molecules, whose expression is up-regulated in atherosclerotic pericytes 169 is likely to be involved in LDL-induced phenotypic changes and activation of pericytes through T-cadherin-mediated activation of Erk 1 2 thyrosine kinase and nuclear translocation of the transcription factor NF-kB. 170 In complicated atherosclerotic lesions, pericytes can be recruited as a part of the angiogenic response and then be involved in the intraplaque neovascularization. T-cadherin could potentially mediate LDL-induced recruitment of pericytes to neovessels. 169 In the plaque, local induction of hepatocyte growth factor in vascular CD31 + ECs can activate c-Met receptors on the surface of pericytes and also recruit pericytes to neovascularization via stimulation of PI3K/Akt signalling.
171
T-cadherin could probably mediate the effects of atherogenic LDL on the chondrogenic differentiation of pericytes and, therefore, contribute to the vascular wall remodelling in the atherosclerotic aorta. Cadherin molecule is an essential component of the canonic Wnt/b-catenin signalling. 172 In addition, several Wnt receptors including LDL-receptorlike proteins 5 and 6 have been found in pericytes. 173 Activation of the Wnt/b-catenin signalling pathway blocks adipogenic differentiation, Figure 4 Pathogenic pathways by which arterial pericytes may contribute to atherosclerosis. Deposition of atherogenic lipids and local inflammation stimulate phenotypic changes in normal 'resting' pericytes. The cells become activated and acquire the ability to proliferate, migrate, and differentiate to other cell types. Indeed, pericytes may contribute to intraplaque neovascularization, vascular remodelling, vascular calcification, and probably thrombosis, e.g. major pathogenic mechanisms associated with the evolution of the atherosclerotic lesion.
Pericyte-like cells in arteries but stimulates chondrogenesis in pericytes accompanied with an increased Sox-9 expression and glycosaminoglycan accumulation into the ECM. 173 Wnt/b-catenin-dependent differentiation of pericytes towards chondrocytes could be enhanced in the presence of TGF-b 3 174 that is highly expressed by macrophages, foam cells, and VSMCs in the fibrofatty plaque. 175 In addition, TGF-b 3 has been shown to control vascular calcification through bone morphogenetic protein (BMP)2/ 4-mediated mineralization of valve myofibroblasts and mural pericytes. 176 After 8 weeks of culturing in standard growth medium, pericytes spontaneously form large multicellular nodules containing a mineralized matrix. 177 The nodules contain osteopontin, osteocalcin, matrix Gla protein, and type I collagen, i.e. all essential constituents of calcified vessels. 178 Within the nodules, hydroxyapatite crystals have been found and the ratio of calcium to phosphate was similar to that found in the bone. 177 Interestingly, calcifying vascular cells found in the mineralizing nodules of calcified arteries can also express the pericyte-specific antigen 3G5, 71 although they exhibit less multipotent differentiation potential than pericytes. 64 Wilkinson et al. 179 showed that 3G5-positive pericytes located in the human atherosclerotic arterial intima and media are able to express vascular calcification-associated factor that regulates osteogenic differentiation of pericytes. These findings can suggest the potential involvement of pericytes in the induction of ectopic vascular calcification. 180 The proinflammatory microenvironment in conjunction with growth factors and cytokines secreted by ECs in the atherosclerotic lesion may permit osteogenic differentiation of resident vascular cells such as pericytes and VSMCs. 180 Intraplaque neovascularization also contributes to ectopic calcification by delivering pericytes into the lesion where they may be subjected to an osteogenic fate. 180 Furthermore, Juchem et al. 181 found a pericyte-like population of subendothelial cells located in the central regions of atherosclerotic lesions and which possessed high thrombogenic properties through overexpression of the tissue factor. This attracts aggregation of platelets to the endothelium-denuded aortic wall existing in advanced atherosclerotic plaques and may contribute to the feared fulminant thromboembolic clotting of affected vessels during the final stage of atherosclerotic disease. 181 Possible pathogenic pathways by which arterial pericytes may contribute to atherosclerosis are shown in scheme in Figure 4 .
Conclusions
Accumulated data indicate that networks of pericyte-like cells exist in normal non-atherosclerotic intima, and that pericyte-like cells can be involved in the early stages of atherogenesis. The pathogenic role of arterial pericytes and pericyte-like cells might be also important in advanced and complicated atherosclerotic lesions via realizing mechanisms of vascular remodelling, ectopic ossification, intraplaque neovascularization, and probably thrombosis. Thus, pericyte-like cells may provide several pathways by which this subendothelial cell subpopulation can contribute to the development of atherosclerotic lesions.
